MICHAEL G ATIEH
CIK 1072501 · EVP, CFO, & CBO, Treasurer · last filed 2026-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$13.13M
Companies
7
Total Filings
58
Lifetime Open-Market Net
-$7.82M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CB | Director | 40,014 | $328.14 | $13.13M | -$2.38M | 22 | 2026-05-26 |
| Oyster Point Pharma, Inc. (OYST) Delisted | Director | 8,671 | $11.17 | $96.9K | $0 | 4 | 2023-01-04 |
| ECOR | Director | — | $10.25 | — | $0 | 3 | 2021-06-15 |
| IVERIC bio, Inc. (OPHT) Delisted | EVP, CFO, & CBO, Treasurer | 367 | — | — | -$9.4K | 3 | 2016-01-05 |
| Chubb Ltd (ACE) Delisted | Director | 38,618 | — | — | -$1.85M | 14 | 2015-05-26 |
| OSI PHARMACEUTICALS INC (OSIP) Delisted | Exec. VP & CFO | 32,447 | — | — | -$3.40M | 10 | 2008-12-16 |
| Chubb Ltd (ACEpC) Delisted | Director | 29,341 | — | — | -$185.7K | 2 | 2007-12-10 |
Recent Filings · Page 2 of 6
58 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-05-23 | CB | Mixed | +161 | -$157.0K | EDGAR |
| 2021-08-20 | CB | Sell (S) | −2,944 | -$548.2K | EDGAR |
| 2021-06-15 | ECOR | Grant (A) | — | $0 | EDGAR |
| 2021-06-09 | Oyster Point Pharma, Inc. (OYST) Delisted | Grant (A) | +3,466 | $0 | EDGAR |
| 2021-05-24 | CB | Mixed | +652 | -$71.6K | EDGAR |
| 2021-02-12 | CB | Sell (S) | −1,000 | -$165.4K | EDGAR |
| 2020-10-13 | Oyster Point Pharma, Inc. (OYST) Delisted | Grant (A) | +19,695 | $0 | EDGAR |
| 2020-06-16 | ECOR | Grant (A) | — | $0 | EDGAR |
| 2020-05-22 | CB | Mixed | +1,412 | -$32.3K | EDGAR |
| 2019-11-13 | CB | Sell (S) | −1,500 | -$226.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.